المؤلفون: Dimopoulos, Ma, Moreau, P, Palumbo, A, Joshua, D, Pour, L, Hájek, R, Facon, T, Ludwig, H, Oriol, A, Goldschmidt, H, Rosiñol, L, Straub, J, Suvorov, A, Araujo, C, Rimashevskaya, E, Pika, T, Gaidano, G, Weisel, K, Goranova Marinova, V, Schwarer, A, Minuk, L, Masszi, T, Karamanesht, I, Offidani, M, Hungria, V, Spencer, A, Orlowski, Rz, Gillenwater, Hh, Mohamed, N, Feng, S, Chng, Wj, ENDEAVOR Investigators: Leahy, M, Kerridge, I, Durrant, S, Cooney, J, Horvath, N, Rowlings, P, Hahn, U, Fay, K, Renwick, W, Quach, H, Taylor, K, Ho, Sj, Johnston, A, Kasparu, H, Delforge, M, Schots, H, Vekemans, Mc, Offner, F, Wu, Kl, Doyen, C, Bittencourt, R, Duarte, G, Maiolino, A, Schaan, M, Scheliga, A, Zadra, C, Gercheva, L, Mihaylov, G, Grudeva Popova, Z, Sandhu, I, Reiman, A, Kanjeekal, S, Dueck, G, Leblanc, R, Tay, J, White, D, Maisnar, V, Scudla, V, Gregora, E, Hajek, R, Stoppa, Am, Karlin, L, Garderet, L, Fermand, Jp, Lenain, P, Rigaudeau, S, Eveillard, Jr, Escoffre Barbe, M, Knop, S, Kropff, M, Rollig, C, Munder, M, Langer, C, Mugge, Lo, Hanel, M, Niederwieser, D, Dimopoulos, M, Egyed, M, Szomor, A, Borbenyi, Z, Illes, A, Yehuda, Db, Benyamini, N, Nagler, A, Mittleman, M, Izhar, H, Cavo, M, De Fabritiis, P, Petrini, Mario, Foa, R, Gobbi, M, Rossi, G, Guglielmelli, T, Lazzaro, A, Musto, P, Gozzetti, A, Takazako, N, Izumi, T, Chou, T, Ozaki, S, Hatake, K, Suzuki, K, Uike, N, Asakura, S, Kosugi, H, Handa, H, Matsumoto, M, Tobinai, K, Iida, S, Kizaki, M, Miyamoto, T, Shibayama, H, Ando, K, Ishikawa, T, Ishida, T, Sugiura, I, Izutsu, K, Taniwaki, M, Lee, Jh, Kim, K, Kim, Js, Min, Ck, Yoon, Ss, Lee, Jo, Suh, C, Simpson, D, Ganly, P, Blacklock, H, Doocey, R, Chiruka, S, Hellmann, A, Gornik, S, Komarnicki, M, Malgorzata, Calbecka, Grosicki, S, Jurczyszyn, A, Stoia, R, Gheorghita, E, Danaila, Cd, Abdulkadyrov, K, Zaritskiy, A, Andreeva, N, Balakireva, T, Podoltseva, E, Rossiev, V, Pristupa, A, Hsieh, Ws, Gopalakrishnan, Sk, Mistrik, M, Rocafiguera, Ao, Mateos, V, Rubia, J, Dachs, Lr, Sanchez, Jm, Alegre, A, Bargay, J, de Oteyza JP, Martinez, J, Chen, Ty, Lin, Tl, Liu, Jh, Wang, Mc, Yeh, Sp, Huang, Sy, Vinnyk, Y, Kriachok, I, Pylypenko, H, Shparyk, Y, Kaplan, P, Karamanesht, L, Rekhtman, G, Romanyuk, N, Kaiser, M, Mehta, A, Williams, C, Basu, S, Rabin, N, Ramasamy, K, Hunter, H, Tholouli, E, Lebovic, D, Siegel, D, Wang, M, Niesvizky, R, Kovacsovics, T, Hurd, D, Gabrail, N, Matous, J, Pendergrass, K, Agrawal, M, Boccia, R, Chandra, S, Kassim, A, Stanisic, S, Coleman, M, Gersten, T, Braunschweig, I, Chowdhury, S, Sahovic, E.

المساهمون: Dimopoulos, Meletios A, Moreau, Philippe, Palumbo, Antonio, Joshua, Dougla, Pour, Ludek, Hájek, Roman, Facon, Thierry, Ludwig, Heinz, Oriol, Albert, Goldschmidt, Hartmut, Rosiñol, Laura, Straub, Jan, Suvorov, Aleksandr, Araujo, Carla, Rimashevskaya, Elena, Pika, Toma, Gaidano, Gianluca, Weisel, Katja, Goranova-Marinova, Vesselina, Schwarer, Anthony, Minuk, Leonard, Masszi, Tamá, Karamanesht, Ievgenii, Offidani, Massimo, Hungria, Vania, Spencer, Andrew, Orlowski, Robert Z, Gillenwater, Heidi H, Mohamed, Nehal, Feng, Shibao, Chng, Wee-Joo, Cavo, M, Laboratory of Molecullar and Cellular Therapy, Clinical sciences

مصطلحات موضوعية: Oncology, Male, Clinical Trial, Phase III, Dexamethasone, Ixazomib, Bortezomib, chemistry.chemical_compound, 0302 clinical medicine, immune system diseases, hemic and lymphatic diseases, Antineoplastic Combined Chemotherapy Protocols, Elotuzumab, Multiple myeloma, education.field_of_study, Research Support, Non-U.S. Gov't, Medicine (all), Anemia, Multicenter Study, Survival Rate, 030220 oncology & carcinogenesis, Randomized Controlled Trial, Hypertension, Retreatment, Oligopeptide, Female, Multiple Myeloma, Oligopeptides, Human, medicine.drug, medicine.medical_specialty, Aged, Disease-Free Survival, Follow-Up Studies, Humans, Pneumonia, Thrombocytopenia, Population, Follow-Up Studie, 03 medical and health sciences, Internal medicine, medicine, Comparative Study, education, Antineoplastic Combined Chemotherapy Protocol, business.industry, medicine.disease, Carfilzomib, Surgery, chemistry, Proteasome inhibitor, business, 030215 immunology

وصف الملف: STAMPA

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba65034270a7f1716f664ed2276b519e
http://hdl.handle.net/11573/935153

المؤلفون: Kiladjian JJ; CIC 1427, Inserm, Université Paris Cité, 75010, Paris, France. jean-jacques.kiladjian@aphp.fr.; Centre d'Investigations Cliniques, AP-HP, Hôpital Saint-Louis, Paris, 75010, France. jean-jacques.kiladjian@aphp.fr., Marin FF; Morales Meseguer University General Hospital, Regional Center of Blood Donation. CIBERER. UCAM. IMIB-Murcia, Murcia, Spain., Al-Ali HK; University Hospital Halle (Saale), Krukenberg Cancer Center Halle, Halle, Germany., Alvarez-Larrán A; Department of Hematology, Hospital Clínic of Barcelona, Barcelona, Spain., Beggiato E; University Hospital City of Health and Science of Turin - Hospital Molinette, Complex Structure of Hematology, Torino, Italy., Bieniaszewska M; Medical University of Gdańsk, Gdańsk, Poland., Breccia M; Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy., Buxhofer-Ausch V; Department of Internal Medicine I for Hematology with Stem Cell Transplantation, Hemostaseology and Medical Oncology, Ordensklinikum Linz Elisabethinen, Johannes Kepler University Linz, Linz, Austria.; Medical Faculty, Johannes Kepler University Linz, Linz, Austria., Cerna O; Clinic of Internal Hematology, University Hospital Kralovske Vinohrady, Prague, Czech Republic., Crisan AM; Fundeni Clinical Institute, Center for Hematology and Bone Marrow Transplantation, București, Romania., Danaila CD; Department of Clinical Hematology, Regional Institute of Oncology, Iasi, Romania., De Stefano V; Fondazione Policlinico Gemelli IRCCS, Section of Hematology, Catholic University, Rome, Italy., Döhner K; Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany., Empson V; AOP Health, Vienna, Austria., Gora-Tybor J; Department of Hematooncology, Copernicus Memorial Hospital, Lodz, Poland.; Department of Hematology, Medical University of Lodz, Lodz, Poland., Griesshammer M; Department of Oncology and Hematology, Ruhr University Bochum, Johannes Wesling Hospital Minden, Minden, Germany., Grosicki S; Medical University of Silesia, Katowice, Poland., Guglielmelli P; Department of Hematology, Careggi University Hospital, Florence, Italy., García-Gutierrez V; Hospital Universitario Ramón y Cajal, Madrid (IRYCIS), Madrid, Spain.; Universidad de Alcalá, Madrid, Spain., Heidel FH; Clinic for Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School (MHH), Hannover, Germany., Illés A; Faculty of Medicine, Department of Internal Medicine, Division of Hematology, University of Debrecen, Debrecen, Hungary., Tomuleasa C; Ion Chiricuta Institute of Oncology, Hematology Department and Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania., James C; University Bordeaux, INSERM, BMC, U1034, F-33600, Pessac, France.; Laboratory of Hematology, Bordeaux University Hospital, Bordeaux, France., Koschmieder S; Faculty of Medicine, Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation (Medical Clinic IV), RWTH Aachen University, Aachen, Germany., Krauth MT; Department of Internal Medicine I, Clinical Department of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria., Krejcy K; AOP Health, Vienna, Austria., Lazaroiu MC; Department of Hematology, Policlinica de Diagnostic Rapid Brasov, Brasov, Romania., Mayer J; University Hospital Brno, Department of Internal Medicine, Hematology and Oncology, Masaryk University, Brno, Czech Republic., Nagy ZG; Department of Internal Medicine and Hematology, Division of Hematology, Semmelweis University, Budapest, Hungary., Nicolini FE; Centre Léon Bérard, Lyon, France., Palandri F; IRCCS Azienda Ospedaliero-Universitaria di Bologna and Istituto di Ematologia Seràgnoli, Bologna, Italy., Pappa V; University General Hospital Attikon, Athens, Greece., Reiter AJ; Medical Clinic III, Hematology and Internistic Oncology, University Hospital Mannheim, Mannheim, Germany., Sacha T; Department of Hematology, Jagiellonian University Hospital, Kraków, Poland., Schlager S; AOP Health, Vienna, Austria., Schmidt S; Department of Internal Medicine V (Hematology and Oncology), Medical University Innsbruck, Innsbruck, Austria., Terpos E; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece., Unger M; AOP Health, Vienna, Austria., Wölfler A; Department of Internal Medicine, Clinical Divison of Hematology, Medical University Graz, Graz, Austria., Cirici BX; Institut Català d' Oncologia- Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain., Klade C; AOP Health, Vienna, Austria.

المصدر: Annals of hematology [Ann Hematol] 2024 Jul; Vol. 103 (7), pp. 2299-2310. Date of Electronic Publication: 2024 Mar 04.

نوع المنشور: Clinical Trial Protocol; Journal Article

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Interferon alpha-2*/therapeutic use , Interferon alpha-2*/adverse effects , Interferon-alpha*/therapeutic use , Interferon-alpha*/adverse effects , Polyethylene Glycols*/therapeutic use , Polyethylene Glycols*/adverse effects , Polyethylene Glycols*/administration & dosage , Recombinant Proteins*/therapeutic use , Recombinant Proteins*/adverse effects , Recombinant Proteins*/administration & dosage , Thrombocythemia, Essential*/drug therapy, Adult ; Aged ; Female ; Humans ; Male ; Middle Aged ; Prospective Studies ; Treatment Outcome ; Multicenter Studies as Topic ; Clinical Trials, Phase III as Topic